Rocket Doctor Is Now In-Network for Aetna in New York State for Medicare and Commercial Health Insurance
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) announced that its digital health platform is now in-network with Aetna in New York State for both Medicare and commercial insurance plans. This credentialing enables Aetna's members to access Rocket Doctor's virtual healthcare services with reduced out-of-pocket costs.
The company's platform offers urgent care, chronic disease management, preventive and mental health services. Rocket Doctor is already operating in New York through partnerships with EngageWell IPA and the CVS Health Foundation's Healthy Aging Program, which received $1 million in funding to provide free virtual health screenings for adults over 60.
Additionally, the company granted 64,896 RSUs and 16,224 stock options to a consultant, with options exercisable at C$0.67 per share over a three-year period.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) ha comunicato che la sua piattaforma di salute digitale è ora in-network con Aetna nello Stato di New York, sia per piani Medicare che commerciali. Questa accreditazione permette agli iscritti Aetna di utilizzare i servizi sanitari virtuali di Rocket Doctor con costi diretti ridotti.
La piattaforma dell'azienda offre servizi di assistenza urgente, gestione delle malattie croniche, prevenzione e salute mentale. Rocket Doctor è già attiva a New York tramite collaborazioni con EngageWell IPA e il CVS Health Foundation's Healthy Aging Program, che ha ricevuto 1 milione di dollari per fornire screening sanitari virtuali gratuiti agli over 60.
Inoltre, l'azienda ha assegnato a un consulente 64.896 RSU e 16.224 opzioni su azioni, con opzioni esercitabili a C$0,67 per azione nell'arco di tre anni.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) anunció que su plataforma de salud digital ya está en la red de Aetna en el Estado de Nueva York, tanto para planes Medicare como comerciales. Esta acreditación permite a los afiliados de Aetna acceder a los servicios de atención virtual de Rocket Doctor con menores costos de bolsillo.
La plataforma de la compañía ofrece atención urgente, manejo de enfermedades crónicas, servicios preventivos y salud mental. Rocket Doctor ya opera en Nueva York mediante asociaciones con EngageWell IPA y el CVS Health Foundation's Healthy Aging Program, que recibió 1 millón de dólares para ofrecer cribados de salud virtuales gratuitos a mayores de 60 años.
Adicionalmente, la compañía otorgó a un consultor 64.896 RSU y 16.224 opciones sobre acciones, con opciones ejercitables a C$0,67 por acción durante un período de tres años.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF)는 자사의 디지털 헬스 플랫폼이 뉴욕주에서 메디케어 및 상업 보험 플랜 모두에 대해 Aetna 네트워크에 포함되었다고 발표했습니다. 이 자격 인정으로 인해 Aetna 가입자는 Rocket Doctor의 가상 의료 서비스를 더 낮은 본인 부담으로 이용할 수 있게 됩니다.
회사의 플랫폼은 응급 진료, 만성질환 관리, 예방 및 정신 건강 서비스를 제공합니다. Rocket Doctor는 이미 EngageWell IPA 및 CVS Health Foundation의 Healthy Aging Program과의 협력을 통해 뉴욕에서 운영 중이며, 해당 프로그램은 60세 이상 성인을 위한 무료 가상 건강 검진 제공을 위해 100만 달러의 자금을 받았습니다.
또한 회사는 컨설턴트에게 64,896 RSU 및 16,224 스톡옵션을 부여했으며, 옵션은 3년 기간에 걸쳐 주당 C$0.67에 행사할 수 있습니다.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) a annoncé que sa plateforme de santé numérique fait désormais partie du réseau de Aetna dans l'État de New York, pour les régimes Medicare et commerciaux. Cette habilitation permet aux membres d'Aetna d'accéder aux services de santé virtuels de Rocket Doctor avec des coûts directs réduits.
La plateforme de la société propose des services de soins d'urgence, de gestion des maladies chroniques, de prévention et de santé mentale. Rocket Doctor est déjà présent à New York via des partenariats avec EngageWell IPA et le CVS Health Foundation's Healthy Aging Program, qui a reçu 1 million de dollars pour fournir des dépistages de santé virtuels gratuits aux personnes de plus de 60 ans.
De plus, la société a attribué à un consultant 64 896 RSU et 16 224 options d'achat d'actions, les options étant exerçables à C$0,67 par action sur une période de trois ans.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) gab bekannt, dass seine digitale Gesundheitsplattform in New York State sowohl für Medicare- als auch für kommerzielle Versicherungspläne nun im Netzwerk von Aetna aufgenommen ist. Diese Akkreditierung ermöglicht Aetna-Mitgliedern den Zugang zu den virtuellen Gesundheitsdiensten von Rocket Doctor mit geringeren Zuzahlungen.
Die Plattform des Unternehmens bietet Notfallversorgung, Management chronischer Erkrankungen, Präventions- und psychische Gesundheitsdienste. Rocket Doctor ist bereits in New York tätig, und zwar durch Partnerschaften mit EngageWell IPA und dem CVS Health Foundation's Healthy Aging Program, das 1 Million Dollar erhielt, um kostenlose virtuelle Gesundheits-Checks für Personen über 60 anzubieten.
Zusätzlich hat das Unternehmen einem Berater 64.896 RSUs und 16.224 Aktienoptionen gewährt, wobei die Optionen über einen Zeitraum von drei Jahren zu C$0,67 pro Aktie ausübbar sind.
- Secured in-network status with Aetna, providing access to 39 million members across 16 states
- Expanded market presence through partnership with CVS Health Foundation's $1M Healthy Aging Program
- Diversified service offering including urgent care, chronic disease management, and mental health services
- Potential dilution from new RSUs and stock options grants
- Rocket Doctor is now in-network with Aetna, having been fully credentialed for Medicare and Commercial insurance in New York State.
- Aetna is one of the nation’s largest health insurers, covering 39 million members across 16 states.
- Aetna members in New York now have in-network access to Rocket Doctor’s providers and digital health platform, including urgent care, chronic disease management, preventive and mental health services.
- Rocket Doctor is already active in New York through its partnership with EngageWell IPA and the CVS Health Foundation’s Healthy Aging Program.
- Credentialing strengthens Rocket Doctor AI’s U.S. market presence and mission to improve healthcare access, affordability and equity.
New York, NY , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with Aetna in New York State, having been fully credentialed for Medicare and commercial plans.
This milestone expands Rocket Doctor’s ability to provide in-network care to Aetna members throughout the state. By combining urgent care, primary care and mental health, alongside connected medical devices and proprietary software, Rocket Doctor delivers high-quality care virtually that is both affordable and accessible, especially for patients on Medicaid and Medicare, and in rural and underserved communities.
“Being credentialed with Aetna in New York is an exciting step forward in our journey to make healthcare more accessible and equitable,” said Dr. William Cherniak, Chief Executive Officer of Rocket Doctor Inc. “Aetna members across the state can now benefit from Rocket Doctor’s digital-first approach to care, which empowers physicians and reduces barriers for patients. This milestone builds on our active partnerships in New York and reinforces our commitment to transforming healthcare delivery for the better.”
Rocket Doctor’s programs include urgent care, chronic disease management, preventive health and mental health services, enabling patients to see licensed physicians from home. With in-network status, Aetna members in New York can access these services with lower out-of-pocket costs and greater convenience.
Rocket Doctor is also active in New York through its partnership with EngageWell IPA and the CVS Health Foundation, which launched the Healthy Aging Program earlier this year. The pilot initiative provides free, virtual health screenings for adults over 60 in New York City, including assessments for heart health, cognitive function and mental health, along with personalized follow-up support from community health workers. The program, backed by
Rocket Doctor AI continues to expand its payer and health system partnerships across North America. As part of this growth, the company also announced that its new U.S. over-the-counter (OTC) ticker symbol is AIRDF.
Further, the Company has granted 64,896 restricted share units (“RSUs”) and 16,224 stock options (“Options”) to a consultant of Rocket Doctor Inc., the Company’s wholly-owned subsidiary. The Options are each exercisable for one common share of the Company at an exercise price of C
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.
Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.
To learn more about Rocket Doctor AI Inc’s products and services, contact:
www.rocketdoctor.ai or email: info@rocketdoctor.ai
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io
For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
